题名

基因與細胞禁藥治理-一個STS取向的考察

并列篇名

The Governance of Gene and Cell Doping: An Investigation Using the STS Approach

DOI

10.29818/SS.202109_(39).0002

作者

孫佳婷(Chia-Ting Sun)

关键词

治理 ; 禁用清單 ; 基因科技 ; 科技與社會 ; 基因與細胞禁藥 ; Governance ; Prohibited List ; Gene Technology ; Science, Technology and Society (STS) ; Gene and Cell Doping

期刊名称

運動文化研究

卷期/出版年月

39期(2021 / 09 / 01)

页次

33 - 78

内容语文

繁體中文

中文摘要

基因科技之技術範疇廣泛,涉入運動領域的多元方式,為我們帶來許多新議題與挑戰。但目前在臺灣,深探基因科技、基因與細胞禁藥如何可能影響運動領域的文獻仍少見,尤其缺乏運動人文與社會學者之參與。因此,本文目的在試圖增補既有研究之視域,拓展大眾對其之理解並作為運動領域未來建構治理模式之參考。本文主要工作在探查當前國際社會對基因與細胞禁藥的治理,並透過爬梳WADA之〈禁用清單〉(Prohibited List)重思基因科技之介入,兼論在運動領域中對基因科技進行治理可能遭遇的一些困境。主要研究方法為檔案分析方法,材料為IOC與WADA等組織所發布之文件,並試圖以科技與社會(science, technology and society, STS)之視角開展論述。本文發現,國際之生物倫理守則與WADA之〈禁用清單〉為基因與細胞禁藥治理的主要依據,該清單在M3內容及類目之修訂,皆與基因科技發展進程呈現並進,從其演變可觀察到運動與社會情勢之變遷。而大眾對基因的強烈興趣、商業化的基因市場、國家對基因科技的治理與使用態度,皆可能成為運動領域較難對基因科技、基因與細胞禁藥進行治理的因素。本文認為,反思現有倫理規範與價值,回顧當前的決策判準,關注運動領域的知識建構及科技風險問題是當前必要之舉。

英文摘要

Gene technology encompasses a wide range of techniques, and as it began to be employed in the field of sports, new issues and challenges have therefore emerged. However, in Taiwan, there has been a lack of relevant studies on how gene technology along with gene and cell doping may affect the field of sports, especially in the domains of sports humanities and social science. As such, the purpose of this study is to supplement the existing research, extend the public's understanding on this subject, and serve as a reference for building related governance models in the field of sports in the future. This study primarily focuses on examining the international community's current governance on gene and cell doping as well as reflecting on the intervention of gene technology in the field of sports by reviewing WADA's "Prohibited List." In addition, dilemmas and difficulties that may be encountered in the governance of gene technology in the field of sports are also discussed in the last part of this study. Document analysis is the main research method, with documents issued by international organizations including the IOC and the WADA as the research materials, and the paradigm of science, technology, and society (STS) as the fundamental framework for developing the discussion. The findings show that the world's current governance on gene and cell doping is based on the international code of bioethics and WADA's "Prohibited List," in which the revisions of the prohibited method M3 appeared to move along with the development of gene technology, indicating the changes in sports and social situations. Meanwhile, the public's strong interest in genes, the commercialization of the gene market, and different countries' usage and attitude towards gene technology may also make it difficult for the field of sports to govern gene technology and gene and cell doping. To achieve governance effectiveness, reflecting on existing ethics and values, reviewing current decision-making criteria, and learning the knowledge construction and technology risk in the field of sports are all necessary actions to be taken.

主题分类 社會科學 > 體育學
参考文献
  1. 吳忠芳(2005)。耐力運動表現與血管緊縮素轉化酶。中華體育季刊,19(4),10-16。
    連結:
  2. 林瑞興,吳銘庭(2006)。ACE基因型與運動員心臟及耐力運動表現。中華體育季刊,20(1),31-39。
    連結:
  3. 張鵬遠,徐台閣(2006)。血管張力素轉化酶及α-輔肌動蛋白基因與運動表現之關係。中華體育季刊,20(3),28-35。
    連結:
  4. 楊惠茹,許美智(2012)。運動禁藥──蛋白酵素之違規摻假。大專體育,123,71-77。
    連結:
  5. 蔡友月(2014)。基因科學與認同政治:原住民DNA、台灣人起源與生物多元文化主義的興起。台灣社會學,28,1-58。
    連結:
  6. 蔡友月(2012)。科學本質主義的復甦?基因科技、種族∕族群與人群分類。台灣社會學,23,155-194。
    連結:
  7. 蔡友月,李宛儒(2016)。想像未來:台灣人體生物資料庫、基因利基與國族建構。台灣社會學,32,109-169。
    連結:
  8. BBC, “Russia State-Sponsored Doping Across Majority of Olympic Sports, Claims Report,” 2016. 〈 https://www.bbc.com/sport/36823453〉 , 13 May 2021.
  9. Bomtempo, Tiago Vieira(2016).Doping Genético e Eugenia: Diálogos Além do Esporte.Revista Latinoamericana de Bioética,16(2),82-101.
  10. Botzenhardt, Suzan,Tug, Suzan,Simon, Perikles(2014).Conventional and Genetic Talent Identification in Sports: Will Recent Developments Trace Talent?.Sports Medicine,44(11),1489-1503.
  11. Burgess, Michael(2001).Beyond Consent: Ethical and Social Issues in Genetic Testing.Nature Reviews Genetics,2,147-151.
  12. Callier, Shawneequa(2012).Genetic Privacy in Sports: Clearing the Hurdles.Recent Patents on DNA & Gene Sequences,6(3),224-228.
  13. Camporesi, Silvia,McNamee, Mike(2018).Bioethics, Genetics and Sport.London:Routledge.
  14. Cantelmo, Rebeca Araujo(2019).Gene Doping: Present and Future.European Journal of Sport Science,20(8),1093-1101.
  15. Council of Europe, “Czech Republic Signs the Additional Protocol on Genetic Testing,” 2017.〈 https://www.coe.int/en/web/bioethics/-/genetic-protocol-signature〉 , 15 Jul. 2018.
  16. Duster, Troy(2001).The Sociology of Science and the Revolution in Molecular Biology.The Blackwell Companion to Sociology,London:
  17. Epstein, David(2014).The Sport Gene: Talent, Practice and the Truth about Success.London:Yellow Jersey Press.
  18. Fischetto, Giuseppe,Bermon, Stéphane(2013).From Gene Engineering to Gene Modulation and Manipulation: Can We Prevent or Detect Gene Doping in Sports?.Sports medicine,43(10),965-977.
  19. Hsu, Kate(2015).Expedited CO2 Respiration in People with Miltenberger Erythrocyte Phenotype GP. Mur.Scientific Reports,5,1-13.
  20. International Testing Agency, “Statutes,” 2018.〈 https://ita.sport/structure/〉 , 02 Mar. 2019.
  21. Irwin, Alan(2008).STS Perspectives on Scientific Governance.The Handbook of Science and Technology Studies,London:
  22. Jolly, Rhonda(2013).Background NotesBackground Notes,Australia:.
  23. Lewontin, Richard C.(1991).Biology as Ideology: The Doctrine of DNA.New York:Harper.
  24. Loland, Sigmund(2002).Fair Play in Sport: A Moral Norm System.East Sussex:Psychology Press.
  25. Mazzeo, Filomena(2020).Updated Evidence Report for the Anti-Doping Research: Analysis from 2008 to 2018 for Performance-Enhancing Drugs and Gene Doping Test Development.Journal of Physical Education & Sport,20(4),2378-2385.
  26. Mehlman, Maxwell J.(2009).Genetic Enhancement in Sport: Ethical, Legal, and Policy Concerns.Performance Enhancing Technologies in Sports: Ethical, Conceptual and Scientific Issues,Baltimore:
  27. Miah, Andy(2007).Genetics, Bioethics and Sport.Sport, Ethics and Philosophy,1(2),146-158.
  28. Miah, Andy(2004).Genetically Modified Athletes: Biomedical Ethics, Gene Doping and Sport.London:Routledge.
  29. Morais, Talita Cavalcante Arruda de,Monteiro, Pedro Sadi(2017).Concepts of Human Vulnerability and Individual Integrity in Bioethics.Bioetica Rivista Interdisciplinare,25(2),311-319.
  30. Mori, Maurizio,Neri, Demetrio(2001).Perils and Deficiencies of the European Convention on Human Rights and Biomedicine.Journal of Medicine and Philosophy,26(3),323-333.
  31. Neuberger, Elmo Wanja Immanuel,Simon, Perikles(2017).Gene and Cell Doping: The New Frontier-Beyond Myth or Reality.Acute Topics in Anti-Doping,Basel:
  32. Orig3n, “Website,” 2020. 〈https://shop.orig3n.com/products/gameplan〉 , 30 Oct. 2020.
  33. Patel, Seema,Ian, Varley(2019).Exploring the Regulation of Genetic Testing in Sport.Entertainment and Sports Law Journal,17(1),5.
  34. Ranisch, Robert(2020).When CRISPR Meets Fantasy: Transhumanism and the Military in the Age of Gene Editing.Transhumanism: The Proper Guide to a Posthuman Condition or a Dangerous Idea?,Cham:
  35. Rankinen, Tuomo(2016).No Evidence of a Common DNA Variant Profile Specific to World Class Endurance Athletes.PloS One,11(1),e0147330.
  36. Rutter, Michael(2006).Genes and Behavior: Nature-Nurture Interplay Explained.Malden:Blackwell Publishing.
  37. Keating Steve, “Exclusive: U.S. Threat to Pull WADA Funding Could Leave Americans Out of Olympics,” 2020. 〈 https://www.reuters.com/article/us-sport-doping-olympics-usa-exclusive-idUSKBN25U33H〉 , 12 May 2021.
  38. Synovitz, Ron and Zamira Eshanova, “Uzbekistan Plunges into Gene Pool to Spot Future Olympians,” 〈 https://www.rferl.org/a/uzbekistan-genetic-testing-children-athletes/25224941.html〉 , 9 January 2014.
  39. Tandy-Connor, Stephany(2018).False Positive Results Released by Direct-to-Consumer Genetic Tests Highlight the Importance of Clinical Confirmation Testing for Appropriate Patient Care.Genetics in Medicine,20(12),1515-1521.
  40. United Nations Educational Scientific and Cultural Organization, “International Convention against Doping in Sport 2005,” 2005. 〈 http://portal.unesco.org/en/ev.php-URL_ID=31037&URL_DO=DO_TOPIC&URL_SECTION=201.html〉 , 10 May 2021. http://portal.unesco.org/en/ev.php-URL_ID=31037&URL_DO=DO_TOPIC&URL_SECTION=201.html
  41. United Nations Educational, Scientific and Cultural Organization, “Intergovernmental Bioethics Committee,” 2019. 〈 http://www.unesco.org/new/en/social-and-human-sciences/themes/bioethics/intergovernmental-bioethics-committee/〉 , 08 Mar. 2019.
  42. United States Anti-Doping Agency, “Frequently Asked Questions,” 2021. 〈 https://www.usada.org/resources/faq/〉 , 10 May 2021.
  43. Vlahovich, Nicole(2017).Ethics of Genetic Testing and Research in Sport: A position Statement from the Australian Institute of Sport.British Journal of Sports Medicine,51(1),5-11.
  44. Wells, Dominic(2008).Genetic Engineering in Athletes.The BMJ Online,337,63-64.
  45. Williams, Alun G.,Wackerhage, Henning,Day, Stephen H(2016).Genetic Testing for Sports Performance, Responses to Training and Injury Risk: Practical and Ethical Considerations.Medicine and Sport Science,61,105-109.
  46. World Anti-Doping Agency, “Frequently Asked Questions: Therapeutic Use Exemptions,” 2016. 〈 https://www.wada-ama.org/en/media/news/2016-09/wada-releases-frequently-asked-questions-faqs-on-therapeutic-use-exemptions-tues〉 , 04 Aug. 2018.
  47. World Anti-Doping Agency, “Expert Advisory Groups,” 2021.〈 https://www.wada-ama.org/en/who-we-are/governance/expert-advisory-groups〉 , 03 March 2021.
  48. World Anti-Doping Agency, “Funding by Governments,” 2021. 〈 https://www.wada-ama.org/en/funding-by-governments 〉 , 13 May 2021.
  49. World Anti-Doping Agency, “Prohibited List Q&A,” 2018a. 〈 https://www.wada-ama.org/en/questions-answers/prohibited-list-qa#item-1419 〉 , 07 Aug. 2019.
  50. World Anti-Doping Agency(2005).World Anti-Doping Agency, The Stockholm Declaration, Montreal: World Anti-Doping Agency, 2005..
  51. World Anti-Doping Agency, “Play True Magazines,” 2019. 〈 https://www.wada-ama.org/en/resources/search?f%5B0%5D=field_resource_collections%3A12#thumb〉 , 20 Apr 2020.
  52. World Anti-Doping Agency, “Global Anti-Doping Organization Chart,” 2009.〈 https://www.wada-ama.org/en/resources/doping-control-process/global-anti-doping-organization-chart〉 , 03 March 2021.
  53. World Anti-Doping Agency, “Prohibited List Documents,” 2021. 〈 https://www.wada-ama.org/en/resources/science-medicine/prohibited-list-documents〉 , 1 Jan. 2021.
  54. World Anti-Doping Agency, “Prohibited List Documents,” 2018b. 〈 https://www.wada-ama.org/en/resources/science-medicine/prohibited-list-documents〉 , 07 Aug. 2019.
  55. World Anti-Doping Agency, “Code Signatories,” 2018c. 〈 https://www.wada-ama.org/en/what-we-do/the-code/code-signatories〉 , 07 Aug. 2019.
  56. World Anti-Doping Agency, “Code Signatories,” 2021. 〈 https://www.wada-ama.org/en/code-signatories〉 , 10 May 2021.
  57. Zillén, Kavot,Garland, Jameson,Slokenberga, Santa(2017).,Strasbourg:Council of Europe.
  58. 中華奧林匹克委員會,〈治療用途豁免 Q&A〉,〈http://www.antidoping.org.tw/tue.php#0〉,2018.08.02檢索。
  59. 吳睿兒,許美智(2013)。運動禁藥──缺氧誘導因子穩定劑。中華民國體育季刊,27(2),137-144。
  60. 奈沙卡雷, Nessa,黎湛平(譯)(2016).表觀遺傳大革命:現代生物學如何改寫我們認知的基因、遺傳與疾病.臺北:貓頭鷹.
  61. 林媽利(2010).我們流著不同的血液:臺灣各族群身世之謎.臺北:前衛.
  62. 財團法人中華運動禁藥防制基金會,〈藥管法規──國內〉,〈https://www.antidoping.org.tw/regulations/〉,2021.03.12檢索。
  63. 許嫚真,詹貴惠(2011)。運動禁藥之紅血球生成刺激劑。臺灣體育論壇,2,21-30。
  64. 陳瑞麟。,未出版
  65. 楊倍昌(2018)。臺灣科技與社會研究學會:科技公共性的實踐。人文與社會科學簡訊,19(4),215-219。
  66. 蔡友月,〈為何世大運原住民選手那麼厲害?揭開種族基因論點的迷思〉,〈https://twstreetcorner.org/2017/10/24/tsaiyuyueh/〉,2019.09.12檢索。
  67. 薛朗莫艾倫, Sharon,陳志民(譯)(2016).遺傳密碼:我們不是被動的基因繼承者,童年創傷、飲食及生活習慣的改變,都能改變基因體的表現.臺北:大塊.